rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-3-23
|
pubmed:abstractText |
Kinetic resistance to cytotoxic drugs may account for the moderate responsiveness of breast cancer to chemotherapy. In the present study the in vitro effects of estradiol-mediated DNA stimulation on the cellular uptake of the DNA intercalating drug doxorubicin (DOX) were examined in MCF-7 human breast cancer cells.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0167-6806
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-48
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9879776-Antineoplastic Agents,
pubmed-meshheading:9879776-Breast Neoplasms,
pubmed-meshheading:9879776-Chromatography, High Pressure Liquid,
pubmed-meshheading:9879776-Doxorubicin,
pubmed-meshheading:9879776-Estradiol,
pubmed-meshheading:9879776-Female,
pubmed-meshheading:9879776-Flow Cytometry,
pubmed-meshheading:9879776-Hormones,
pubmed-meshheading:9879776-Humans,
pubmed-meshheading:9879776-Microscopy, Fluorescence,
pubmed-meshheading:9879776-Neoplasms, Hormone-Dependent,
pubmed-meshheading:9879776-Tumor Cells, Cultured
|
pubmed:year |
1998
|
pubmed:articleTitle |
Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro.
|
pubmed:affiliation |
Department of Medical Oncology, Rotterdam Cancer Institute, University Hospital, The Netherlands. westhoff@onch.azr.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|